Newsletters
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
Your vote counts! Support the UN proposal for an AMR-focused Sustainable Development Goal (SDG) Indicator
Dear All, Your vote counts! The UN’s Inter-Agency and Expert Group on Sustainable Development Goal Indicators (IAEG-SDGs) is conducting an open ...
Read More >
Non-traditional antibiotics: A pipeline review and an analysis of key development challenges
Dear All, Non-traditional alternatives to antibiotics have excited a lot of interest in the past few years but we’ve seen ...
Read More >
Clever pipeline visualization from Pew + New guidance documents from FDA
Dear All, Two very brief notes today… First, Pew Trusts continues to work to provide ways to understand the antibiotic pipeline. ...
Read More >
New mechanisms for antibiotic reimbursement in the United States: CMS’s IPPS FY2020 Final Rule
Dear All (and with thanks to Kevin Outterson for substantial help with this newsletter), On August 2, 2019, the US government ...
Read More >
Public meeting on the LPAD Pathway: Post-meeting thoughts (wonkish)
Long and wonkish note alert — please refresh your coffee before you start reading! Dear All: I was able to ...
Read More >
CMS Administrator Seema Verma: “Volume-based incentives undervalue antibiotics”
Dear All, In a marvelous series of tweets, Seema Verma (current Administrator of the US Centers for Medicare and Medicaid Services) ...
Read More >
The UK jumps in with a subscription model for antibiotics!
Dear All: We had hints back in January that this was coming (see this post), but now it is really happening! ...
Read More >
AMR stays on the G20’s to-do list with calls for Push and Pull mechanisms
Aside: Please look closely at the forward calendar. In addition to two new webinars from GARDP’s REVIVE project, there is a ...
Read More >
Two jobs: CARB-X R&D Chief / Short-term WHO consultancy (Sep ’19 to Feb ’20)
Dear All: Two interesting job posts this week. Could one of them be for you? First, CARB-X seeks a Boston-based full-time ...
Read More >
An apple a day (used to) keep the doctor away
Dear All: OK … enough with bad news, at least for today. In today’s edition of XKCD (link), we learn ...
Read More >
FDA Workshop: Leveraging Randomized Clinical Trials to Generate Real-World Evidence for Regulatory Purposes
Dear All: The idea of using real-world evidence (RWE) as a way to support development of novel agents (including antibiotics!) ...
Read More >
Help update the WHO clinical antibacterial pipeline analysis
Dear All: As you know, WHO produced a pipeline update with a cut-off date of 1 July 2018. It’s now ...
Read More >
Why vaccines for AMR? What is their value? Grant opportunity for research on this topic / Great NPR TED Radio Hour on vaccines
Dear All:First, and with a closing date of 12 Sep 2019, Wellcome Trust is offering grants of up to GBP 750k for research investigating ...
Read More >
CARB-X-supported webinar: New Infection Research initiative from the Cystic Fibrosis Foundation (CFF)
Dear All: The Cystic Fibrosis Foundation (CFF) has a standing list of funding opportunities (link), including an annual cycle to ...
Read More >
Extended deadline: NIAID call for proposals for therapeutics & vaccines for resistant bacteria
Also note several new webinars in the forward meeting list! Dear All: NIAID currently has an open BAA (Broad Agency ...
Read More >
Go, BARDA! / Outstanding Op-Ed in Forbes by Rick Bright
Dear All: Rick Bright, Director of BARDA, posted an outstanding commentary (link) in Forbes on 10 May 2019 on the ...
Read More >
Start your engines! BARDA antibiotic procurement RFP / CARB-X 2019 funding round webinar
Dear All: Two things of note this afternoon… First, the previously noted BARDA RFP to acquire biothreat antibiotics is now posted here with submissions accepted through 21 ...
Read More >
Scary, Scarier, Scariest (Part 2): What can YOU do about it?
Long note alert— apologies! Get a cup of coffee and settle in… Dear All: My 22 Apr 2019 note entitled Scary, ...
Read More >
CARB-X 2019: Calls announced covering non-traditionals, vaccines-biologics, diagnostics, and direct-acting small molecules
Aside: There is now an application link for the Mar 2020 Antibacterial R&D GRC meeting. See calendar listing below my ...
Read More >
FDA AMDAC (26 April 2019) on IM Bacitracin for pneumonia in infants: Follow-up note
Addendum: This is the third in a series of newsletters on IM bacitracin. Go here for the prior newsletter and ...
Read More >
